Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Reaching beyond maximum grade: progress and future directions for modernising the assessment and reporting of adverse events in haematological malignancies
Gita Thanarajasingam, Lori M. Minasian, Vishal Bhatnagar, et al.
The Lancet Haematology (2022) Vol. 9, Iss. 5, pp. e374-e384
Open Access | Times Cited: 16

Showing 16 citing articles:

Access to and affordability of CAR T-cell therapy in multiple myeloma: an EBMT position paper
Nico Gagelmann, Anna Sureda, Silvia Montoto, et al.
The Lancet Haematology (2022) Vol. 9, Iss. 10, pp. e786-e795
Closed Access | Times Cited: 34
Consensus position statement on advancing the standardised reporting of infection events in immunocompromised patients
Benjamin W. Teh, Małgorzata Mikulska, Diana Averbuch, et al.
The Lancet Infectious Diseases (2023) Vol. 24, Iss. 1, pp. e59-e68
Closed Access | Times Cited: 17
[Special issue PRO] Considering endpoints for comparative tolerability of cancer treatments using patient report given the estimand framework
John Devin Peipert, Monique Breslin, Ethan Basch, et al.
Journal of Biopharmaceutical Statistics (2024), pp. 1-19
Closed Access | Times Cited: 4
Benefits and Limitations of Real‐World Patient‐Reported Toxicity Symptom Monitoring for Guidelines and Care, as Perceived by Patients, Clinicians, and Guideline Developers
Yolba Smit, L. Verweij, Alan Currie, et al.
Cancer Medicine (2025) Vol. 14, Iss. 8
Open Access
Reducing Adolescent and Young Adult Cancer Outcome Disparities Through Optimized Care Delivery: A Blueprint from the Children's Oncology Group
Melissa Beauchemin, Michael Roth, Susan K. Parsons
Journal of Adolescent and Young Adult Oncology (2023)
Open Access | Times Cited: 10
Precision oncology medicines and the need for real world evidence acceptance in health technology assessment: Importance of patient involvement in sustainable healthcare
Jan Geißler, Lydia Makaroff, Bärbel Söhlke, et al.
European Journal of Cancer (2023) Vol. 193, pp. 113323-113323
Open Access | Times Cited: 6
Racial differences in longitudinal toxicities of anticancer agents in early phase cancer clinical trials
Junki Mizusawa, Hioryuki Sato, Larry Rubinstein, et al.
Cancer Medicine (2023) Vol. 12, Iss. 17, pp. 18098-18109
Open Access | Times Cited: 3
Measuring chronic myeloid leukaemia TKI-related toxic effects in the real world: a systematic review and critical assessment of content validity of patient-reported outcome measures
Yolba Smit, Sanne J J P M Metsemakers, Jeroen J.W.M. Janssen, et al.
The Lancet Haematology (2023) Vol. 10, Iss. 10, pp. e849-e859
Closed Access | Times Cited: 3
The role of SF3B1 and NOTCH1 in the pathogenesis of leukemia
Shiva Abolhasani, Seyyed Sina Hejazian, Vahid Karpisheh, et al.
IUBMB Life (2022) Vol. 75, Iss. 3, pp. 257-278
Closed Access | Times Cited: 3
Managing infectious challenges in the age of molecular‐targeted therapies for adult hematological malignancies
Manan Shah, Firas El Chaer, Dora Y. Ho, et al.
Transplant Infectious Disease (2024) Vol. 26, Iss. 3
Closed Access
SOHO State of the Art Updates and Next Questions | Measuring Patient-Reported Outcomes (PROs) and Treatment Tolerability in Patients with Hematologic Malignancies
Ajay Major, Amylou C. Dueck, Gita Thanarajasingam
Clinical Lymphoma Myeloma & Leukemia (2024)
Closed Access
Patient-Reported Tolerability in Oncology Drug Development
Jessica Roydhouse, Ethan Basch, Monique Breslin, et al.
ICSA book series in statistics (2024), pp. 219-254
Closed Access
Comparison of Survivorship Care Guidelines for Patients With Lymphoma: Recommendations for Harmonization and Future Research Agenda
Bryan Valcárcel, Kerry J. Savage, Brian K. Link, et al.
JCO Oncology Practice (2024)
Closed Access
EXABS-138-LYM Measuring Physical Function and Tolerability on Treatment in Patients With Hematologic Malignancies
Ajay Major, Amylou C. Dueck, Gita Thanarajasingam
Clinical Lymphoma Myeloma & Leukemia (2023) Vol. 23, pp. S48-S51
Closed Access
Goals to score: The need for a minimum reporting dataset in studies of infection events in immunocompromised patients
Benjamin W. Teh, Małgorzata Mikulska, Nicolas J. Mueller, et al.
Transplant Infectious Disease (2023) Vol. 26, Iss. 1
Open Access
Post CAR-T cytopenia: poorly understood and clinically challenging
Mark R. Dowling, Michael Dickinson
Leukemia & lymphoma/Leukemia and lymphoma (2022) Vol. 63, Iss. 8, pp. 1774-1776
Closed Access
Page 1

Scroll to top